Helix Sequencing vs Dante Labs

Dante Labs (now rebranded as Dante Omics AI) and Helix Sequencing represent two fundamentally different approaches to consumer genomics. Dante Labs ships you a saliva kit and performs 30x whole genome sequencing — reading virtually all 6 billion base pairs of your DNA. Helix Sequencing accepts data you already have from 23andMe, AncestryDNA, or other providers and runs the deepest health analysis available: 3,550+ polygenic risk scores, 34-gene pharmacogenomics, and AI integration.

On paper, Dante Labs offers a compelling product. In practice, the company has faced serious operational challenges that affect the customer experience. This comparison examines both what each service promises and what it actually delivers.

Quick Comparison

What Dante Labs Offers

Dante Labs, founded in Italy in 2016, offers 30x whole genome sequencing using Illumina next-generation sequencing technology. Their premium bundles include 150+ health reports across 800+ conditions, covering cardiology, oncology, rare diseases, carrier screening, nutrigenomics, pharmacogenomics, and wellness categories. They also offer ancestry analysis and a B2B platform for clinicians.

Their pricing is aggressive: the standard 30x WGS kit lists at $499 but is frequently discounted to $199 during promotions, making it one of the cheapest WGS options available. They also accept uploads from 23andMe and AncestryDNA for report generation.

In late 2024, Dante rebranded to “Dante Omics AI” and announced generative AI integration with GPU-accelerated multiomics analysis. As of this writing, these AI features have been announced in press releases but independent verification of consumer-facing AI features being live and functional has not been confirmed.

The Reliability Problem

This is where the comparison becomes important. Dante Labs has some of the lowest customer satisfaction scores in the direct-to-consumer genomics industry:

The most common complaints include: delivery delays of 6-10+ months (vs the advertised 8-week turnaround), unresponsive customer service with emails going unanswered for months, and raw data (FASTQ/BAM files) being locked behind a paywall after 30 days. Some customers have reported receiving used kits containing other people’s saliva.

In October 2024, Dante Labs experienced a financial crisis, failing to pay employee wages and initiating collective dismissals. The company has since been acquired by Bio Cell Tech FZCO. They have rebranded three times in three years (Dante Labs → Dante Genomics → Dante Omics AI), which compounds the trust issue.

When Dante Labs Makes Sense

Despite the operational issues, there are scenarios where Dante Labs may be the right choice:

When to Choose Helix Sequencing

Whole Genome Sequencing vs Deep Imputation

A common question is whether WGS is inherently “better” than genotyping with imputation. The answer depends on what you need the data for.

Where WGS Wins

Whole genome sequencing directly reads every position in your genome. This means it captures rare variants(frequency <1%) and structural variants (insertions, deletions, copy number changes) that genotyping chips cannot detect. For rare disease diagnosis or research into uncommon genetic conditions, WGS provides data that no chip-based approach can match.

Where Imputation Is Sufficient

For polygenic risk scores and pharmacogenomics— the two most actionable categories of genomic health analysis — deep imputation from a consumer chip produces results that are comparable to WGS at a fraction of the cost. Helix uses Beagle 5.5 to expand ~700K chip variants to 28M+, achieving approximately 95% accuracy for common variants (MAF >5%). Since PRS models are built primarily from common variants, imputed data works well.

The practical implication: if your goal is health analysis and actionable insights, you do not necessarily need WGS. The clinical value comes from interpretation, not just raw data volume. 6 billion data points with basic reports provide less actionable health information than 28 million well-analyzed variants with 3,550+ validated risk models.

Privacy and Data Ownership

Helix Sequencingoperates on zero data retention. Your DNA file is processed, analyzed, and permanently deleted. You receive a SHA-256 deletion certificate as cryptographic proof. After analysis, nothing remains on Helix’s servers.

Dante Labsretains personal data for 10 years after account termination (citing legal compliance). More controversially, FASTQ and BAM files — the raw sequencing reads that represent the most complete version of your data — are only downloadable for the first 30 days after results are ready. After that, they are locked behind a paywall. VCF files remain accessible, but losing access to your own raw sequencing data without warning is a significant data ownership concern.

Frequently Asked Questions

Key Takeaways